As the Managing Partner of Esplanade Ventures, Canada’s top digital health VC, I’m proud to be an early backer of Osteoboost and their exceptional team. I was first drawn to the company after meeting CEO Laura Yecies and learning about the immense potential of the first non-drug treatment for osteoporosis and osteopenia. This is not a niche problem, half of all women and one in four men over the age of 50 will suffer from a debilitating fracture due to the loss of bone density. Even NASA has studied this problem in astronauts who rapidly lose bone density in space. In fact, Osteoboost builds directly on that research, and has already shown an 85% retention in bone density for women at risk of Osteoporosis. This kind of impact can mean the difference between a loved one living a normal, independent life or struggling to walk. Since we first met Laura, the Osteoboost team has consistently executed well. Laura herself is a proven operator with multiple exits (including one to Apple) and held senior leadership roles at Netscape, Yahoo Mail, and Check Point. Since launching in May, Osteoboost has generated $2M in revenue with virtually no marketing, showing clear early evidence of market demand. The opportunity is massive, in the U.S. alone, Osteoporosis represents a $10B market impacting nearly 64 million Americans, globally, it exceeds $100B. Osteoboost’s ambitions go well beyond the device itself. The company is building a community and holistic solution for bone health, recently acquiring and successfully integrating the Wellen exercise program to advance its integrated vision. This is a great time to back the company with a proven launch, impressive early growth, defensible patents, and clear exit potential. Osteoboost aligns perfectly with Esplanade Venture’s mission to transform healthcare through bold, patient-focused innovation, especially for women. Osteoboost is a long-awaited breakthrough in bone health. It’s giving millions of women with Osteopenia and low bone density a new path to a stronger, more lively future. A path that’s effective, non-invasive, drug-free, and backed by science.